Diagnostic procedure for the determination of the Nox2 protein

Patent number:

EP3495821A1

Italia.svg
No items found.

A diagnostic method for the quantitative detection of the Nox2 protein in a biological sample, comprising the following operations i) normalize the protein content of the biological sample to a value of 1 μg of protein per 100 μl of sample, ii) put in contacting the normalized biological sample with an anti-Nox2 monoclonal detection antibody, wherein the detection antibody is directly conjugated to a detection label, and iii) detecting the formation of the Nox2 protein-detection antibody complex.

Countries:
Italy
Regions:
No items found.
Centers:
SAPIENZA UNIVERSITA DI ROMA
Other entities:
Sectors:
Health
Subsectors:
Biotechnology, Analysis of biological materials
TRL Level:
TRL 6 – technology demonstrated in relevant environment (industrially relevant environment in the case of key enabling technologies)
BRL Level:
BRL1: Hypothesizing on possible business concept
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The patent is applicable in the field of cardiovascular and inflammatory disease. In particular, the sNox2-dp analysis by ELISA Kit can help to stratify the cardiovascular and inflammatory risk.

Comments

Other related patents

Health

New composition to drastically reduce toxic compounds in tobacco smoke.

Countries
Spain
Know more
Health
Other
Chemicals

ANTIPARASITIC COMPOUNDS

Countries
Spain
Know more
Health

PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOF

Countries
Spain
Know more
Get back to patents directory